BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3893510)

  • 21. Healthy passive cigarette smokers have increased pulmonary alveolar permeability.
    Beadsmoore C; Cheow HK; Szczepura K; Ruparelia P; Peters AM
    Nucl Med Commun; 2007 Feb; 28(2):75-7. PubMed ID: 17198345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation of differential cell counts of bronchoalveolar lavage fluid.
    Baughman R; Strohofer S; Kim CK
    Arch Pathol Lab Med; 1986 Apr; 110(4):341-3. PubMed ID: 2420304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clearance of Tc-99m DTPA in hemodialysis and peritoneal dialysis: concise communication.
    Wainer E; Boner G; Lubin E; Rosenfeld JB
    J Nucl Med; 1981 Sep; 22(9):768-71. PubMed ID: 7024480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clearance of 99m-technetium-labelled DTPA in asbestos-exposed subjects without clinical or radiological evidence of interstitial lung disease.
    Gellert AR; Langford JA; Winter RJ; Lewis CA; Tolfree SE; Rudd RM
    Br J Dis Chest; 1985 Jan; 79(1):37-42. PubMed ID: 3986111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asbestosis. Bronchoalveolar lavage fluid proteins and their relationship to pulmonary epithelial permeability.
    Gellert AR; Perry D; Langford JA; Riches PG; Rudd RM
    Chest; 1985 Nov; 88(5):730-5. PubMed ID: 3902389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of pulmonary alveolar epithelial integrity by the detection of restriction to diffusion of hydrophilic solutes of different molecular sizes.
    Mason GR; Peters AM; Bagdades E; Myers MJ; Snook D; Hughes JM
    Clin Sci (Lond); 2001 Mar; 100(3):231-6. PubMed ID: 11222107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technetium-99m DTPA aerosol and gallium scanning in acquired immune deficiency syndrome.
    Picard C; Meignan M; Rosso J; Cinotti L; Mayaud C; Revuz J
    Clin Nucl Med; 1987 Jul; 12(7):501-6. PubMed ID: 3301147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tumor necrosis factor alpha in bronchoalveolar lavage fluid and its production by alveolar macrophages with asbestos exposure].
    Tokuyama T; Yoneda T; Tsukaguchi K; Yoshikawa M; Fu A; Tomoda K; Nakaya M; Narita N; Tamura M; Miyazaki R
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Mar; 32(3):205-10. PubMed ID: 8189639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asbestos bodies in bronchoalveolar lavage.
    De Vuyst P; Jedwab J; Dumortier P; Vandermoten G; Vande Weyer R; Yernault JC
    Am Rev Respir Dis; 1982 Dec; 126(6):972-6. PubMed ID: 7181238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lymphocyte populations in bronchoalveolar lavage fluid in various interstitial lung diseases].
    Müller S; Kramer H; Bergmann KC; Wiesner B; Grollmuss H; Unger U; Christ R; Eckert H
    Z Erkr Atmungsorgane; 1984; 163(2):140-5. PubMed ID: 6506803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid in vivo assessment of toxicity of respirable particles: a concise report.
    Bégin R; Rola-Pleszczynski M; Massé S; Berthiaume Y; Drapeau G
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):267-78. PubMed ID: 6878867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchoalveolar lavage fluid cellular profile in workers exposed to chrysotile asbestos.
    Kokkinis FP; Bouros D; Hadjistavrou K; Ulmeanu R; Serbescu A; Alexopoulos EC
    Toxicol Ind Health; 2011 Oct; 27(9):849-56. PubMed ID: 21421677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristics of the intrapulmonary cytogram in compensatory lung hypertrophy].
    Romanova LK; Mladkovskaia TB
    Biull Eksp Biol Med; 1987 Mar; 103(3):363-6. PubMed ID: 3828522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flow cytometric characterization of cell populations in bronchoalveolar lavage and bronchial brushings from patients with chronic obstructive pulmonary disease.
    Hodge SJ; Hodge GL; Holmes M; Reynolds PN
    Cytometry B Clin Cytom; 2004 Sep; 61(1):27-34. PubMed ID: 15351979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mass, number and size of lung fibres in the pathogenesis of asbestosis in sheep.
    Sébastien P; Bégin R; Masse S
    J Exp Pathol (Oxford); 1990 Feb; 71(1):1-10. PubMed ID: 2155635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bronchoalveolar lavage and transbronchial lung biopsy in sarcoidosis and extrinsic allergic alveolitis.
    Valenti S; Scordamaglia A; Crimi P; Mereu C
    Eur J Respir Dis; 1982 Nov; 63(6):564-9. PubMed ID: 7173351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of common therapeutic concentrations of oxygen on lung clearance of 99mTc DTPA and bronchoalveolar lavage albumin concentration.
    Griffith DE; Holden WE; Morris JF; Min LK; Krishnamurthy GT
    Am Rev Respir Dis; 1986 Aug; 134(2):233-7. PubMed ID: 3527005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small-airways dysfunction in never smoking asbestos exposed Danish plumbers.
    Døssing M; Groth S; Vestbo J; Lyngenbo O
    Int Arch Occup Environ Health; 1990; 62(3):209-12. PubMed ID: 2189832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of asbestos bodies in the human lung as determined by bronchoalveolar lavage.
    Teschler H; Konietzko N; Schoenfeld B; Ramin C; Schraps T; Costabel U
    Am Rev Respir Dis; 1993 May; 147(5):1211-5. PubMed ID: 8484633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.